185 related articles for article (PubMed ID: 37264016)
21. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Stattin P; Rinaldi S; Biessy C; Stenling R; Riboli E; Hallmans G; Kaaks R
Int J Cancer; 2003 Oct; 107(1):89-93. PubMed ID: 12925961
[TBL] [Abstract][Full Text] [Related]
22. Exploration of the platelet proteome in patients with early-stage cancer.
Sabrkhany S; Kuijpers MJE; Knol JC; Olde Damink SWM; Dingemans AC; Verheul HM; Piersma SR; Pham TV; Griffioen AW; Oude Egbrink MGA; Jimenez CR
J Proteomics; 2018 Apr; 177():65-74. PubMed ID: 29432918
[TBL] [Abstract][Full Text] [Related]
23. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
24. Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy.
Serilmez M; Özgür E; Karaman S; Gezer U; Duranyıldız D
Cancer Biomark; 2019; 25(2):177-184. PubMed ID: 31104010
[TBL] [Abstract][Full Text] [Related]
25. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
[TBL] [Abstract][Full Text] [Related]
27. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
[TBL] [Abstract][Full Text] [Related]
28. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
Cao Y; Nimptsch K; Shui IM; Platz EA; Wu K; Pollak MN; Kenfield SA; Stampfer MJ; Giovannucci EL
Int J Cancer; 2015 May; 136(10):2418-26. PubMed ID: 25348852
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
; Guida F; Sun N; Bantis LE; Muller DC; Li P; Taguchi A; Dhillon D; Kundnani DL; Patel NJ; Yan Q; Byrnes G; Moons KGM; Tjønneland A; Panico S; Agnoli C; Vineis P; Palli D; Bueno-de-Mesquita B; Peeters PH; Agudo A; Huerta JM; Dorronsoro M; Barranco MR; Ardanaz E; Travis RC; Byrne KS; Boeing H; Steffen A; Kaaks R; Hüsing A; Trichopoulou A; Lagiou P; La Vecchia C; Severi G; Boutron-Ruault MC; Sandanger TM; Weiderpass E; Nøst TH; Tsilidis K; Riboli E; Grankvist K; Johansson M; Goodman GE; Feng Z; Brennan P; Johansson M; Hanash SM
JAMA Oncol; 2018 Oct; 4(10):e182078. PubMed ID: 30003238
[TBL] [Abstract][Full Text] [Related]
31. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract][Full Text] [Related]
32. Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial.
Brown D; Zingone A; Yu Y; Zhu B; Candia J; Cao L; Ryan BM
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):110-118. PubMed ID: 30297515
[TBL] [Abstract][Full Text] [Related]
33. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
Jenab M; Riboli E; Cleveland RJ; Norat T; Rinaldi S; Nieters A; Biessy C; Tjønneland A; Olsen A; Overvad K; Grønbaek H; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Boeing H; Pischon T; Trichopoulos D; Oikonomou E; Trichopoulou A; Panico S; Vineis P; Berrino F; Tumino R; Masala G; Peters PH; van Gils CH; Bueno-de-Mesquita HB; Ocké MC; Lund E; Mendez MA; Tormo MJ; Barricarte A; Martínez-García C; Dorronsoro M; Quirós JR; Hallmans G; Palmqvist R; Berglund G; Manjer J; Key T; Allen NE; Bingham S; Khaw KT; Cust A; Kaaks R
Int J Cancer; 2007 Jul; 121(2):368-76. PubMed ID: 17372899
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
37. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Peeters PH; Berrino F; Dossus L; Biessy C; Olsen A; Tjonneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Téhard B; Nagel G; Linseisen J; Boeing H; Lahmann PH; Trichopoulou A; Trichopoulos D; Koliva M; Palli D; Panico S; Tumino R; Sacerdote C; van Gils CH; van Noord P; Grobbee DE; Bueno-de-Mesquita HB; Gonzalez CA; Agudo A; Chirlaque MD; Barricarte A; Larrañaga N; Quiros JR; Bingham S; Khaw KT; Key T; Allen NE; Lukanova A; Slimani N; Saracci R; Riboli E; Kaaks R
Endocr Relat Cancer; 2006 Jun; 13(2):593-605. PubMed ID: 16728585
[TBL] [Abstract][Full Text] [Related]
38. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.
Han JY; Kim JY; Lee SH; Yoo NJ; Choi BG
Lung Cancer; 2011 Nov; 74(2):293-9. PubMed ID: 21440951
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
